Naghib S, Mohammad-Jafari K
Curr Top Med Chem. 2024; 24(14):1185-1211.
PMID: 38424436
DOI: 10.2174/0115680266286460240220073334.
Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T
Signal Transduct Target Ther. 2023; 8(1):293.
PMID: 37544972
PMC: 10404590.
DOI: 10.1038/s41392-023-01536-y.
Makhathini S, Mdanda S, Kondiah P, Kharodia M, Rumbold K, Alagidede I
Pharmaceutics. 2022; 14(12).
PMID: 36559335
PMC: 9787506.
DOI: 10.3390/pharmaceutics14122839.
Deiss-Yehiely E, Brucks S, Boehnke N, Pickering A, Kiessling L, Hammond P
Bioconjug Chem. 2022; 33(11):2065-2075.
PMID: 36282941
PMC: 9942780.
DOI: 10.1021/acs.bioconjchem.2c00412.
Foglizzo V, Marchio S
Cancers (Basel). 2022; 14(10).
PMID: 35626078
PMC: 9139219.
DOI: 10.3390/cancers14102473.
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman P, Hood E, Ferguson L, Zhao Z, Siegel D, Mitragotri S
Adv Drug Deliv Rev. 2021; 178:113992.
PMID: 34597748
PMC: 8556370.
DOI: 10.1016/j.addr.2021.113992.
Peptides and Dendrimers: How to Combat Viral and Bacterial Infections.
Falanga A, Del Genio V, Galdiero S
Pharmaceutics. 2021; 13(1).
PMID: 33466852
PMC: 7830367.
DOI: 10.3390/pharmaceutics13010101.
Stability of Alkyl Chain-Mediated Lipid Anchoring in Liposomal Membranes.
Gleue L, Schupp J, Zimmer N, Becker E, Frey H, Tuettenberg A
Cells. 2020; 9(10).
PMID: 33003620
PMC: 7599733.
DOI: 10.3390/cells9102213.
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy.
Juan A, Cimas F, Bravo I, Pandiella A, Ocana A, Alonso-Moreno C
Pharmaceutics. 2020; 12(9).
PMID: 32854255
PMC: 7558516.
DOI: 10.3390/pharmaceutics12090802.
What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
Leung A, Amador C, Wang L, Mody U, Bally M
Pharmaceutics. 2019; 11(3).
PMID: 30884782
PMC: 6471263.
DOI: 10.3390/pharmaceutics11030124.
Precision engineering of targeted nanocarriers.
Deci M, Liu M, Thai Dinh Q, Nguyen J
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018; 10(5):e1511.
PMID: 29436157
PMC: 6089677.
DOI: 10.1002/wnan.1511.
The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.
Youngren-Ortiz S, Chougule M
Hawaii J Med Public Health. 2017; 76(11):318-325.
PMID: 29164017
PMC: 5694976.
Cancer nanomedicine: progress, challenges and opportunities.
Shi J, Kantoff P, Wooster R, Farokhzad O
Nat Rev Cancer. 2016; 17(1):20-37.
PMID: 27834398
PMC: 5575742.
DOI: 10.1038/nrc.2016.108.
Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser.
Ghannam M, El Gebaly R, Fadel M
Lipids Health Dis. 2016; 15:68.
PMID: 27044538
PMC: 4820905.
DOI: 10.1186/s12944-016-0235-2.
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.
Kamaly N, Yameen B, Wu J, Farokhzad O
Chem Rev. 2016; 116(4):2602-63.
PMID: 26854975
PMC: 5509216.
DOI: 10.1021/acs.chemrev.5b00346.
Cancer targeted therapeutics: From molecules to drug delivery vehicles.
Liu D, Auguste D
J Control Release. 2015; 219:632-643.
PMID: 26342659
PMC: 5503194.
DOI: 10.1016/j.jconrel.2015.08.041.
Co-encapsulating the fusogenic peptide INF7 and molecular imaging probes in liposomes increases intracellular signal and probe retention.
Burks S, Legenzov E, Martin E, Li C, Lu W, Kao J
PLoS One. 2015; 10(3):e0120982.
PMID: 25816348
PMC: 4376389.
DOI: 10.1371/journal.pone.0120982.
Advanced targeted nanomedicine.
Pereira M, Arachchige M, Reshetnyak Y, Andreev O
J Biotechnol. 2015; 202:88-97.
PMID: 25615945
PMC: 4685670.
DOI: 10.1016/j.jbiotec.2015.01.009.
The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo.
Ng H, Lu A, Lin G, Qin L, Yang Z
Int J Mol Sci. 2014; 16(1):230-55.
PMID: 25547490
PMC: 4307245.
DOI: 10.3390/ijms16010230.
Albumin-fatty acid interactions at monolayer interface.
Gew L, Misran M
Nanoscale Res Lett. 2014; 9(1):218.
PMID: 24910574
PMC: 4029981.
DOI: 10.1186/1556-276X-9-218.